Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor–positive non-small cell lung cancer who might benefit from sequential tyrosine kinase inhibitor treatment.

Autor: Provencio, Mariano1 (AUTHOR) mprovenciop@gmail.com, Serna-Blasco, Roberto1 (AUTHOR), Franco, Fabio1 (AUTHOR), Calvo, Virgina1 (AUTHOR), Royuela, Ana2 (AUTHOR), Auglytė, Milda1 (AUTHOR), Sánchez-Hernández, Alfredo3 (AUTHOR), de Julián Campayo, María3 (AUTHOR), García-Girón, Carlos4 (AUTHOR), Dómine, Manuel5 (AUTHOR), Blasco, Ana6 (AUTHOR), Sánchez, José M.7 (AUTHOR), Oramas, Juana8 (AUTHOR), Bosch-Barrera, Joaquim9 (AUTHOR), Sala, María Á.10 (AUTHOR), Sereno, María11 (AUTHOR), Ortega, Ana L.12 (AUTHOR), Chara, Luis13 (AUTHOR), Hernández, Berta14 (AUTHOR), Padilla, Airam15 (AUTHOR)
Zdroj: European Journal of Cancer. May2021, Vol. 149, p61-72. 12p.
Databáze: Academic Search Ultimate
Externí odkaz: